S3729Referred to Committee

PBM Reporting Transparency Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-01-29
Introduced
3
Cosponsors
S
ⓘ
Type

Sponsor

Mark R. Warner
Mark R. Warner
Democrat · VA · Senator
Votes with party: 76.7% (820 recorded votes)

Full profile: /officials/W000805

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Finance.

2026-01-29

Source: Congress.gov

Plain-English Summary

This bill would require pharmacy benefit managers (the companies that insurance plans use to manage prescription drug coverage) to publicly report detailed information about their business practices, including how they negotiate drug prices and what fees they charge. The transparency requirements would help patients, doctors, and policymakers understand how these middlemen operate and whether they're keeping drug costs artificially high. The measure primarily affects pharmacy benefit managers and could influence how insurance companies and patients access prescription medications.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.